Prometheus Raises $12 Billion at a $41 Billion Valuation

Incubated at Foresite Labs with Arch Ventures in 2024

UCB to Acquire Candid Therapeutics

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for immune reset.

Delivering on the promise of artificial intelligence in science and engineering.

We believe that artificial intelligence will greatly accelerate the pace of human discovery and innovation.

Scientific Discovery

Khartis Therapeutics Emerges with $50M Series B for Thyroid Eye Disease Treatment

From an idea incubated inside Foresite Labs to a $95 million-backed biotechnology company advancing toward the clinic.

Innovation

Towards Biomedical Superintelligence: from AI agents to AI innovators

We laid out 5 principles required for AI to evolve from agents to biomedical innovators, from multimodal representation and experiment-in-the-loop to fit-for-purpose eval and a system around the model.

Incubation platform — Dismantling the barriers to innovation

Learn More

01. People

Our experienced team of scientists, engineers, and operators partners to build the next generation of transformational companies in AI, science, and beyond.

02. Capabilities

Our platform accelerates scientific and technological discovery by integrating AI, data science, and advanced analytics to extract deeper insights and drive innovation.

03. Data Ecosystem

We work across our portfolio to standardize and harmonize data generation and analysis, creating a rich ecosystem that fuels breakthroughs in AI across industries.rn